Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-PINACA and the role of European drug checking services

P. E. OOMEN ; D. SCHORI ; K. TOGEL-LINS ; D. ACREMAN ; S. CHENORHOKIAN ; A. LUF ; A. KARDEN ; C. PAULOS ; E. FORNERO ; E. GERACE ; R. P. J. KONING ; L. GALINDO ; L. A. SMIT-RIGTER ; F. MEASHAM ; M. VENTURA | 2022
Dans International Journal of Drug Policy (Vol.100, February 2022) Article : Périodique

Background: European drug checking services exchange information on drug trends within the Trans European Drug Information (TEDI) network, allowing monitoring and coordination of responses. Starting in Spring 2020, several services detected the [...]

Plus d'info

Ajouter à la sélection

Lien externe

Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene

J. J. PALAMAR ; A. SALOMONE ; E. GERACE ; D. DI CORCIA ; M. VINCENTI ; C. M. CLELAND | 2017
Dans International Journal of Drug Policy (Vol.48, October 2017) Article : Périodique

Background: Data on both known and unknown drug use in the electronic dance music (EDM) scene is important to inform prevention and harm reduction. While surveys are the most common method of querying drug use, additional biological data can hel[...]

Plus d'info

Ajouter à la sélection

Nouveauté

Interpretation of NPS results in real hair samples

A. SALOMONE ; M. VINCENTI ; E. GERACE | 2017
Dans Toxicologie Analytique et Clinique (Vol.29, n°1, Février 2017) Article : Périodique

Today, the use of hair analysis for forensic issues concerning drugs collectively indicated as NPS is still controversial. In particular, little is known about the incorporation into the keratin matrix after intake and the correlation between th[...]

Plus d'info

Ajouter à la sélection

Lien externe

On-site identification of psychoactive drugs by portable Raman spectroscopy during drug-checking service in electronic music events

E. GERACE ; F. SEGANTI ; C. LUCIANO ; T. LOMBARDO ; D. DI CORCIA ; H. TEIFEL ; M. VINCENTI ; A. SALOMONE | 2019
Dans Drug and Alcohol Review (Vol.38, n°1, January 2019) Article : Périodique

INTRODUCTION AND AIMS: Hundreds of new psychoactive substances (NPS) have burst into the marketplace, making both the scientific community and people who use drugs lacking of adequate information about their diffusion and effects. In this scenar[...]

Plus d'info

Ajouter à la sélection

Lien externe

Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012-2021

R. Q. VROLIJK ; F. MEASHAM ; A. QUESADA ; A. LUF ; D. SCHORI ; S. RADLEY ; D. ACREMAN ; J. SMITH ; M. VERDENIK ; D. MARTINS ; M. CUNHA ; C. J. PAULOS ; I. F. PICCININ ; E. GERACE ; A. KARDEN ; R. P. J. KONING ; L. A. SMIT-RIGTER ; M. VENTURA | 2022
Dans Drugs, Habits and Social Policy (Vol.23, n°3, 2022) Article : Périodique

Purpose: The 3,4-methylenedioxymetamphetamine (MDMA) content in ecstasy tablets has increased enormously throughout Europe across the past decade. This study aims to determine whether this is caused by the production of "stronger" tablets (more [...]

Plus d'info

Ajouter à la sélection

Lien externe